<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00558662</url>
  </required_header>
  <id_info>
    <org_study_id>EU Study No-05-000003</org_study_id>
    <nct_id>NCT00558662</nct_id>
  </id_info>
  <brief_title>Randomized Clinical Trial (RCT) to Compare the Efficacy of Coban 2 Versus SSB in the Treatment of Venous Leg Ulcers</brief_title>
  <official_title>Randomized Controlled Clinical Study to Assess the Clinical Efficacy of the 3M™ Coban™ 2 Layer Compression System Compared to a Short-stretch Compression Bandage in the Treatment of Venous Leg Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>3M</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>3M</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study purpose is to compare healing rates, cost effectiveness, quality of life and safety
      of 12 week compression therapy for the treatment of venous leg ulcers with the 3M™ Coban™ 2
      Layer Compression System versus short-stretch compression bandage.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>- venous leg ulcer healing</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>- wound size reduction - HRQoL - treatment-cost based on material consumption and visit costs - sub-bandage pressure measurements - AE/SAE</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">234</enrollment>
  <condition>Venous Ulcer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coban 2 Layer Compression System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Short-Stretch Bandage</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coban 2</intervention_name>
    <description>Bandages will be changed after a wear time of seven days, or in case of product or non-product related reason, which would require a dressing or bandage change.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Coban 2 Layer Compression System</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SSB</intervention_name>
    <description>Bandages will be changed after a wear time of seven days, or in case of product or non-product related reason, which would require a dressing or bandage change.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Rosidal K</other_name>
    <other_name>Rosidal soft</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females, age 18 years or older

          -  Subjects having a venous leg ulcer (stage C6 according CEAP classification, venous
             pathology proved by the presence of reflux (Pr)), which is at least 1 cm in any
             dimension but not larger than 10 cm in any dimension and has at least 5 cm distance to
             additional ulcers.

          -  Subjects who are co-operative, willing to give written informed consent prior to study
             entry, and willing to comply with the study protocol.

          -  Subjects who are able to understand and answer questionnaire items.

          -  Subjects who can walk (with or without a walking aid).

          -  Subjects who have an ABPI (ankle brachial pressure index) of treated leg greater or
             equal to 0,8 as measured within four weeks prior to enrollment.

          -  Subjects with venous incompetence as defined by reflux longer than 1,0 second in at
             least one of the following sites: groin [femoral vein, junction of GSV], mid thigh
             medial [GSV], hollow of the knee [popliteal vein, junction of SSV], mid calf [SSV] in
             the standing position, measured by Doppler, preferably by duplex within the last 12
             month without following active treatment of venous reflux.

        Exclusion Criteria:

          -  Subjects with an ABPI &lt; 0.8 as measured within four weeks prior to enrollment.

          -  Subjects whose condition, in the opinion of the investigator, does not require or
             allow for compression therapy.

          -  Subjects where the potential study ulcer is infected, i.e. showing signs of clinical
             infection (not contamination) as evidenced by purulent, malodorous, or recent increase
             in drainage and/or peri-wound erythema or elevated temperature.

          -  Subjects receiving any systemic antibiotics.

          -  Subjects with diagnosed cancerous ulceration.

          -  Subjects with diabetic foot ulcers (do not exclude diabetics).

          -  Subjects with circumferential wounds.

          -  Subjects who started or significantly changed treatment with mood altering substances
             (e.g. antidepressant drugs) within two weeks prior to enrollment.

          -  Subjects who are participating in any prospective clinical study that can potentially
             interfere with this study.

          -  Subjects who are, in the opinion of the clinical investigator, unsuitable for
             enrollment in this study, for reasons not specified in the exclusion criteria.

          -  Subjects with known allergies against the following products: Coban 2 Layer
             Compression System, Rosidal K, Rosidal soft, Tegaderm Foam, Cavilon NSBF
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolfgang Vanscheidt, Prof MD PhD</last_name>
    <role>Study Chair</role>
  </overall_official>
  <overall_official>
    <last_name>Eberhard Rabe, Prof. MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klnik und Poliklinik für Dermatologie der Universität Bonn</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joachim Dissemond, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinik Essen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Stücker, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik für Dermatologie der Rhur Universität Bochum</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Keith Harding, MB, MRCGP, FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wound Healing Research Unit</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jost van der Kleij, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Atrium Medisch Centrum Parkstad in Heerlen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karl-Heinz Konz, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kliniken Maria Hilf Mönchengladbach</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Schroijen, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dermatology, Ziekenhuis de Lievensberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dinanda Kolbach, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. Kolbach Kliniek</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karin Timm</last_name>
    <role>Principal Investigator</role>
    <affiliation>IJsselland Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gill Wicks</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tissue Viability</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sylvie Hampton, MA BSc (Hons) DpSN RGN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tissue Viability</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Helger Stege, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum Lippe-Lemgo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rik Couvreur, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Military Hospital Queen Astrid</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Toon Sabbe, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AZ alma Eeklo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rudi Vossaert, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wound Centre AZ St. Elisabeth</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wound Centre AZ St. Elisabeth</name>
      <address>
        <city>Zottegem</city>
        <state>Godveerdegemstraat 69</state>
        <zip>9620</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AZ Alma Eeklo</name>
      <address>
        <city>Eeklo</city>
        <state>Moeie 13</state>
        <zip>9900</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Military Hospital Queen Astrid</name>
      <address>
        <city>Brussels</city>
        <state>Neder-Over-Heembeek</state>
        <zip>1120</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Dermatologie der Rhr Universität Bochum - Venenzentrum der dermatologischen und gefäßchirurgischen Kliniken</name>
      <address>
        <city>Bochum</city>
        <zip>44805</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik für Dermatologie der Universität Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen, Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prof. Vanscheidt, MD, PhD</name>
      <address>
        <city>Freiburg</city>
        <zip>79102</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Lippe_lemgo</name>
      <address>
        <city>Lemgo</city>
        <zip>32657</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kliniken Maria Hilf</name>
      <address>
        <city>Mönchengladbach</city>
        <zip>41069</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis de Lievensberg, Department of Dermatology</name>
      <address>
        <city>Bergen op Zoom</city>
        <zip>4600AC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IJsselland Hospital</name>
      <address>
        <city>Capelle aan den IJssel</city>
        <zip>2906</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atrium Medisch Centrum Parkstad in Heerlen</name>
      <address>
        <city>Heerlen</city>
        <zip>6419</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Kolbach Kliniek</name>
      <address>
        <city>Maastricht</city>
        <zip>6218</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wound Healing Research unit, Cardiff Medicentre</name>
      <address>
        <city>Cardiff</city>
        <zip>CF14 4UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tissue Viability</name>
      <address>
        <city>Eastbourne</city>
        <zip>BN21 4RL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trowbridge Community Hospital</name>
      <address>
        <city>Trowbridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2007</study_first_submitted>
  <study_first_submitted_qc>November 14, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2007</study_first_posted>
  <last_update_submitted>November 17, 2011</last_update_submitted>
  <last_update_submitted_qc>November 17, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>compression therapy</keyword>
  <keyword>venous leg ulcer</keyword>
  <keyword>sub bandage pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Monensin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

